Home | Recruitment | News & Events | Customer Support | Contact Us
Reagents
NEW Serology (Epstein Barr Virus) Programme

View Brochure:

RIQAS Infectious Diseases
Enrolment document
Method questionnaire

The RIQAS Epstein Barr Virus quarterly EQA programme is designed to monitor the performance of the parameters listed below. 

  • Liquid ready to use samples for ease of use and convenience
  • 100% human plasma mirrors the performance of patient samples

Cat no:

RQ9153

Vial size:

3 x 1ml (samples shipped 4 times per year)

Frequency:

Quarterly reporting (1 x 12 month cycle), Quantitative and Qualitative Results

Cycle Start Date: 25 June 2012 (Cycle will run from June 2012 to March 2013)

Parameters:

Anti-EBNA IgG
Anti-EBV VCA IgG
Anti-EBV VCA IgM


Please contact marketing@randox.com if you would like to participate

Products

Toxicology

Contract Manufacturing

Randox Engineering
Other Randox Websites

Randox Food Diagnostics
Randox Toxicology
Randox Life Sciences
Randox Health Checks
Randox Online Store
Randox Pharma Services
Randox Testing Services
Drugs of Abuse Testing
RIQAS
Lab Test Blog


Follow us on facebook Follow us on twitter Linked In You Tube

Accreditation